RUEDIGER NAUMANN-ETIENNE - Corporate Board Profile

ENCISION INC

Filing Date	Source Excerpt
2009-06-29	Ruediger Naumann-Etienne (1) 62 Director (1) Member of the Compensation Committee Currently, and except for Ruediger Naumann-Etienne who elected not to receive his compensation, our outside directors receive $1,250 a month for their services. Ruediger Naumann-Etienne elected not to receive his compensation.
2010-07-01	Ruediger Naumann-Etienne (1) 63 Director (1) Member of the Compensation Committee ... Director Compensation ... Ruediger Naumann-Etienne Fees paid in cash $7,500 Option awards $8,100 Total $15,600
2011-07-01	Ruediger Naumann-Etienne (1) 64 Director
2012-07-06	Ruediger Naumann-Etienne (1)(3) 65 Director. (1)Member of the Compensation Committee (3)Member of the Audit Committee. The following table details the total compensation earned by our non-employee directors in fiscal year 2012. Ruediger Naumann-Etienne Fees paid in cash $11,937.50, Option awards $0, All other compensation $0, Total $11,937.50.
2013-07-10	Ruediger Naumann-Etienne has served on our board of directors since October 2008. Mr. Naumann-Etienne has been the General Partner of Intertec Healthcare Partners, a fund investing in medical companies, since 2006. Since 1989, he has also been the owner and Managing Director of Intertec Group, an investment company specializing in the medical technology field. Intertec Group has successfully implemented growth strategies for OEC Medical Systems, Laserscope, Quinton Instruments and Cardiac Science. From 2006 through 2010, he was Chairman of Cardiac Science having previously served as the Chairman of a predecessor company, Quinton Instruments, from 2000 to 2005. He was also CEO of Quinton Instruments from 2000 to 2003. From 1993 until 1996, he was Chairman of OEC Medical Systems and CEO of the same company from 1995 to 1997. Mr. Naumann-Etienne is also a director of Varian Medical Systems and IRIDEX Corporation. Mr. Naumann-Etienne’s extensive experience serving as a director and executive for various companies in the medical technology field is valuable to our board of director’s oversight of the growth and financing of our business. Our outside directors receive $1,250 a quarter for their services and are reimbursed for their out-of-pocket expenses incurred in connection with their service as directors. Option grants to our directors are at the discretion of the board of directors. The following table details the total compensation earned by our non-employee directors in fiscal year 2013. Director Compensation: Ruediger Naumann-Etienne Fees paid in cash ($) 5,000.00 Option awards ($) ― All other compensation ($) ― Total ($) 5,000.00
2014-07-11	Ruediger Naumann-Etienne (1) (3) 67 Director (1)Member of the Compensation Committee (3)Member of the Audit Committee ... The following table details the total compensation earned by our non-employee directors in fiscal year 2014. ... Ruediger Naumann-Etienne 5,000.00 — — 5,000.00 ... The members of the compensation committee are Vern D. Kornelsen, Robert H. Fries and Ruediger Naumann-Etienne. ... Vern D. Kornelsen and Ruediger Naumann-Etienne comprise the audit committee.
2015-07-30	Ruediger Naumann-Etienne has served on our board of directors since October 2008. Mr. Naumann-Etienne has been the General Partner of Intertec Healthcare Partners, a fund investing in medical companies, since 2006. Since 1989, he has also been the owner and Managing Director of Intertec Group, an investment company specializing in the medical technology field. Intertec Group has successfully implemented growth strategies for OEC Medical Systems, Laserscope, Quinton Instruments and Cardiac Science. From 2006 through 2010, he was Chairman of Cardiac Science having previously served as the Chairman of a predecessor company, Quinton Instruments, from 2000 to 2005. He was also CEO of Quinton Instruments from 2000 to 2003. From 1993 until 1996, he was Chairman of OEC Medical Systems and CEO of the same company from 1995 to 1997. Mr. Naumann-Etienne is also a director of Varian Medical Systems and IRIDEX Corporation. Mr. Naumann-Etienne’s extensive experience serving as a director and executive for various companies in the medical technology field is valuable to our board of director’s oversight of the growth and financing of our business. He is a member of the Compensation Committee and Audit Committee. He received total compensation of $8,750 in fiscal year 2015.